Dianthus Therapeutics (DNTH) Change in Account Payables (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Change in Account Payables of $3.0 million for Q3 2025, down 46.84% year-over-year from $5.7 million in Q3 2024, and down 2.75% quarter-over-quarter from $3.1 million in Q2 2025.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Change in Account Payables (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Change in Account Payables history runs 9 years deep, the most recent figure standing at $3.0 million for Q3 2025.
- In Q3 2025, Change in Account Payables fell 46.84% year-over-year to $3.0 million; the TTM figure through Sep 2025 stood at $6.9 million (down 8.53% YoY), while the FY2024 annual figure was $8.2 million, up 1139.18% from the prior year.
- Change in Account Payables for Q3 2025 stood at $3.0 million, down from $3.1 million in the prior quarter.
- The five-year high for Change in Account Payables was $5.7 million in Q3 2024, with the low at -$4.7 million in Q1 2023.
- The 5-year median for Change in Account Payables is $773000.0 (2023), against an average of $627578.9.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables slumped 583.14% in 2022, then soared 631.05% in 2024.
- Dianthus Therapeutics' Change in Account Payables stood at $1.2 million in 2021, then slumped by 129.38% to -$339000.0 in 2022, then jumped by 572.86% to $1.6 million in 2023, then soared by 42.23% to $2.3 million in 2024, then soared by 31.75% to $3.0 million in 2025.
- Business Quant data shows DNTH's Change in Account Payables at $3.0 million in Q3 2025, $3.1 million in Q2 2025, and -$1.5 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | 5.65 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | -2.99 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 773,000.00 |
| Jun 30, 2023 | 3.01 Mn |
| Mar 31, 2023 | -4.73 Mn |
| Dec 31, 2022 | -339,000.00 |
| Sep 30, 2022 | 531,000.00 |
| Jun 30, 2022 | -2.39 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 122,000.00 |
| Jun 30, 2021 | -350,000.00 |
| Mar 31, 2021 | -1.65 Mn |
| Dec 31, 2020 | 1.37 Mn |